Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

BIIBBiogen Inc.

Healthcare·Drug Manufacturers—General·NASDAQ·Mkt cap $30.00B
$209.13
$9.82 (+4.93%) today
IEX feed · not consolidated
Last updated Jul 14, 10:09 AM
66/100 Opportunity
31Risk
74Momentum
66Pullback
65Quality
68Valuation
100Trend
Price & History (up to 5 years)
→
Low 0.00— support · — resistanceHigh 0.00
Technical Indicators
RSI (14)56.4
MACD hist-0.92
ATR (14)6.53
SMA 20204.20
SMA 50197.81
SMA 200179.46
Rel volume1.9x
Boll upper218.54
Boll lower189.87
52w high218.86
52w low121.21
5y high358.01
5y low110.10
Hist. vol34%
Max drawdown-14%
Long-Term UptrendBuy WatchPossible Dip BuyEntry: Pullback Watch
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Biogen Inc. — Drug Manufacturers—General company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Neutral / Needs Confirmation
Opportunity Score
66/100
Risk Level
Low-Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: BIIB is up 4.9% with volume 1.9x its average. Overall, the company is reasonably solid. The long-term trend remains up. Price is holding above key moving averages with constructive structure. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context50
Valuation68
Trend100
Momentum74
Pullback66
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward72
Entry Timing55
Sell Risk30
Risk31

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.

Recent Signals
  • Buy WatchBIIB spiked 4.9% on 1.9x volume.